Cluster headache (CH) has been described as one of the most painful conditions a human can experience. Its nickname, suicide headache, accurately conveys the sentiment many cluster patients feel when in a cluster cycle. CH can be divided into to groups: those that cluster (that is, the headaches occur for weeks, are then gone for many months, then return. This is called episodic cluster), and those that no longer cluster (chronic cluster), but rather occur every day without interruption. Acute therapies include inhaled oxygen and sumatriptan injections, but there are no preventive treatments currently approved by the Food and Drug Administration (FDA).
At NEICR we’re committed to helping cluster headache patients. Over the years, we’ve been involved in more cluster studies then just about any other research organization. Some of these projects have gone on to become fully approved medications by the FDA.
At the moment, we are not recruiting for any Cluster Headache trials. If you would like to receive information on any future trials, please fill out the form below to be added to our contact list. Any information entered below will not be disclosed to any third party and your information will be kept confidential.
Study procedures at NEICR come at no cost to you, and there may be compensation provided for time and travel. To enroll or learn more fill out the form below or call us at 203-914-1903.